Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Novel immune-based therapies for psoriasis.

B Kirby¹, C E M Griffiths

¹Dermatopharmacology Unit, The Dermatology Centre, University of Manchester, Hope Hospital, Salford, Manchester M6 8HD, U.K.

The British Journal of Dermatology

|April 23, 2002

Summary

Psoriasis is a T-cell-mediated autoimmune disease. Recent advancements focus on targeted immune therapies, revealing innate immunity

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Evidence of early coronary atherosclerotic plaque in hidradenitis suppurativa compared to the background population is indicative of myocardial infarction risk.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Retinoids in the treatment of photoageing: A histological study of topical retinoid efficacy in black skin.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

Tofacitinib efficacy, patient-reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase III studies.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024

Same author

HER2-low expression in patients with advanced or metastatic solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Same author

Immunogenicity and pharmacokinetics of guselkumab among patients with moderate-to-severe psoriasis in VOYAGE-1 and VOYAGE-2.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023

Area of Science:

Immunology
Dermatology
Autoimmune Diseases

Background:

Psoriasis is recognized as a T-cell-mediated autoimmune condition.
Immunological understanding has driven the development of targeted therapies.
Cyclosporine exemplifies early immunologically directed treatments.

Purpose of the Study:

To review recent developments in immune-based therapies for psoriasis.
To highlight novel interventions with selective immunological targets.
To discuss how these therapies serve as investigational tools for understanding psoriasis pathogenesis.

Main Methods:

Review of current literature on psoriasis immunology.
Analysis of novel immunologically directed therapies.
Examination of clinical efficacy and side-effect profiles of new treatments.

Main Results:

Novel therapies offer selective immune intervention, aiming for reduced side effects.
Pharmaceutical interventions provide insights into the hierarchy of immune events in psoriasis.
Emerging evidence points to a key role for innate immunity in psoriasis.

Conclusions:

Targeted immune therapies represent a significant advancement in psoriasis treatment.
Understanding the immune basis of psoriasis is crucial for developing effective interventions.
Further research into the role of innate immunity is warranted for future therapeutic strategies.

Related Experiment Videos